Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This early phase I trial studies how well fingolimod works in treating patients with
chemotherapy-induced nerve pain (neuropathy). Fingolimod acts by suppressing immune reactions
in the brain. This study is being done to see if fingolimod can reduce neuropathy caused by
chemotherapy.